Objective: Patients with schizophrenia and schizoaffective disorder suffer from increased
rates of weight gain that might lead to severe medical problems. This study aimed to …

Objective: To study the relationship among factors affecting obesity and overweight in
schizophrenia and bipolar disorder patient, including eating behavior, physical activity, and …

Objective We tested the hypothesis that fasting blood glucose and insulin levels are higher
in schizophrenic subjects on clozapine monotherapy compared with healthy controls and …

Introduction: Obesity, metabolic syndrome, diabetes, hypertension, and other risk factors for
cardiovascular disease occur in persons with schizophrenia at rates twice those in the …

Introduction: The use of antipsychotic medication in the treatment of schizophrenia is linked
to obesity and metabolic syndrome. The link between metabolic syndrome and obesity …

Objective: The rates of obesity and cigarette smoking are much higher in patients with
schizophrenia compared to the general population. This study was to examine whether …

本研究要探討中低強度運動介入對服用Clozapine 之肥胖慢性精神分裂症病患身體組成, 血脂肪,
精神症狀與憂鬱程度的相關影響. 選取某精神專科教學醫院之病患, 運動組, 對照組各14 …

Objective: The presence of obesity and increases in body mass are important risk factors for
cardiovascular disease and diabetes. This study examined the effects of olanzapine …

Obesity is a health problem that is concerning worldwide because it is associated with many
diseases such as hypertension, dyslipidemias, type 2 diabetes, heart diseases, stroke, sleep …

Objective: This study aimed to determine the prevalence of obesity among patients with
schizophrenia and its association with the demographic profile. Methods: This is a cross …